Cana I Make a Systematic Review of a Vaccine

Article Menu

/ajax/scifeed/subscribe

Open Access Systematic Review

A Systematic Review on COVID-19 Vaccine Strategies, Their Effectiveness, and Issues

by ¹ , ^{ii,three,four} , ^v , ⁵ , ^v , ^one,vi , ^one , ^seven , ^v , ⁵ , ^viii , ^1,8 , ^ix,* and ^i,5,*

¹

Gonoshasthaya-RNA Molecular Diagnostic & Inquiry Center, Dhanmondi, Dhaka 1205, People's republic of bangladesh

ⁱⁱ

Strathclyde Institute of Chemist's shop and Biomedical Sciences, University of Strathclyde, Glasgow G1 1XQ, UK

³

Division of Public Health Pharmacy and Management, Schoolhouse of Chemist's, Sefako Makgatho Wellness Sciences Academy, Pretoria 0204, South Africa

⁴

Centre of Medical and Bio-Allied Health Sciences Research, Ajman University, Ajman P.O. Box 346, United Arab Emirates

^v

Section of Microbiology, Jahangirnagar Academy, Savar 1342, Bangladesh

^vi

Department of Community Medicine, Gonoshasthaya Samaj Vittik Medical College, Savar 1344, Bangladesh

⁷

Department of Pharmacology, All India Constitute of Medical Sciences, Jodhpur 342005, Bharat

⁸

Department of Chemist's, BRAC Academy, Dhaka 1212, Bangladesh

⁹

The Unit of Pharmacology, Kinesthesia of Medicine and Defense Wellness, Universiti Pertahanan Nasional Malaysia (National Defence University of Malaysia), Kem Perdana Sugai Besi, Kuala Lumpur 57000, Malaysia

^*

Authors to whom correspondence should exist addressed.

Received: 29 September 2021 / Revised: xviii Nov 2021 / Accepted: 18 November 2021 / Published: 24 Nov 2021

Abstract

COVID-19 vaccines are indispensable, with the number of cases and mortality notwithstanding rising, and currently no medicines are routinely available for reducing morbidity and mortality, apart from dexamethasone, although others are being trialed and launched. To date, merely a limited number of vaccines have been given emergency use dominance by the US Nutrient and Drug Assistants and the European Medicines Agency. At that place is a need to systematically review the existing vaccine candidates and investigate their safety, efficacy, immunogenicity, unwanted events, and limitations. The review was undertaken by searching online databases, i.e., Google Scholar, PubMed, and ScienceDirect, with finally 59 studies selected. Our findings showed several types of vaccine candidates with different strategies against SARS-CoV-2, including inactivated, mRNA-based, recombinant, and nanoparticle-based vaccines, are being developed and launched. We take compared these vaccines in terms of their efficacy, side effects, and seroconversion based on data reported in the literature. We institute mRNA vaccines appeared to take amend efficacy, and inactivated ones had fewer side furnishings and similar seroconversion in all types of vaccines. Overall, global variant surveillance and systematic tweaking of vaccines, coupled with the evaluation and administering vaccines with the same or different technology in successive doses along with homologous and heterologous prime-booster strategy, accept become essential to impede the pandemic. Their effectiveness appreciably outweighs whatsoever concerns with any adverse events. View Total-Text

► ▼ Show Figures

This is an open admission article distributed nether the Artistic Commons Attribution License which permits unrestricted use, distribution, and reproduction in whatsoever medium, provided the original piece of work is properly cited

Supplementary Material

• Supplementary File 1:

  Zilch-Certificate (ZIP, 72 KiB)

Share and Cite

MDPI and ACS Manner

Khandker, S.S.; Godman, B.; Jawad, Grand.I.; Meghla, B.A.; Tisha, T.A.; Khondoker, One thousand.U.; Haq, M.A.; Charan, J.; Talukder, A.A.; Azmuda, N.; Sharmin, S.; Jamiruddin, Thou.R.; Haque, M.; Adnan, N. A Systematic Review on COVID-nineteen Vaccine Strategies, Their Effectiveness, and Issues. Vaccines 2021, 9, 1387. https://doi.org/10.3390/vaccines9121387

AMA Style

Khandker SS, Godman B, Jawad MI, Meghla BA, Tisha TA, Khondoker MU, Haq MA, Charan J, Talukder AA, Azmuda N, Sharmin S, Jamiruddin MR, Haque M, Adnan N. A Systematic Review on COVID-xix Vaccine Strategies, Their Effectiveness, and Bug. Vaccines. 2021; ix(12):1387. https://doi.org/10.3390/vaccines9121387

Chicago/Turabian Mode

Khandker, Shahad Due south., Brian Godman, Doc. I. Jawad, Bushra A. Meghla, Taslima A. Tisha, Mohib U. Khondoker, Md. A. Haq, Jaykaran Charan, Ali A. Talukder, Nafisa Azmuda, Shahana Sharmin, Mohd. R. Jamiruddin, Mainul Haque, and Nihad Adnan. 2021. "A Systematic Review on COVID-nineteen Vaccine Strategies, Their Effectiveness, and Bug" Vaccines ix, no. 12: 1387. https://doi.org/ten.3390/vaccines9121387

Annotation that from the first event of 2016, MDPI journals use article numbers instead of page numbers. Meet farther details here.

Commodity Metrics

Commodity Admission Statistics

For more information on the journal statistics, click here.

Multiple requests from the same IP address are counted as 1 view.

Author Biographies

Brian has published extensively on the use of antimicrobials across sectors and countries in the by ten years, including sub-Saharan Africa and potential ways to improve their utilisation and reduce AMR. This includes multiple papers on their utilisation in hospitals via betoken prevalence and other studies and suggestions for improvement, including pertinent quality indicators. He has also published on the impact of ASPs in hospitals, including preventing surgical site infections. His Google Scholar Commendation List (10528+) can exist viewed at https://scholar.google.com/citations?user=UWVb9ysAAAAJ

We employ cookies on our website to ensure you get the best experience.
Read more nearly our cookies hither.

We accept just recently launched a new version of our website.
Help us to further ameliorate by taking role in this short 5 infinitesimal survey here. here.

mcneilplad1970.blogspot.com

Source: https://www.mdpi.com/2076-393X/9/12/1387

Share this post